Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Estradiol
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Recipient : Hamad Medical Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Oestrogen Treatment for COVID-19 Symptoms
Details : Estradiol is a Hormone drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
April 21, 2021
Lead Product(s) : Estradiol
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Recipient : Hamad Medical Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Testosterone
Therapeutic Area : Endocrinology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism
Details : Testosterone is a Hormone drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hypogonadism.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
February 08, 2013
Lead Product(s) : Testosterone
Therapeutic Area : Endocrinology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
